These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 37548553

  • 1. A feedback loop between lncRNA MALAT1 and DNMT1 promotes triple-negative breast cancer stemness and tumorigenesis.
    Hu Y, He Y, Luo N, Li X, Guo L, Zhang K.
    Cancer Biol Ther; 2023 Dec 31; 24(1):2235768. PubMed ID: 37548553
    [Abstract] [Full Text] [Related]

  • 2. MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction.
    Chen F, Luo N, Hu Y, Li X, Zhang K.
    Cell Physiol Biochem; 2018 Dec 31; 47(5):2147-2158. PubMed ID: 29975921
    [Abstract] [Full Text] [Related]

  • 3. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer.
    Zuo Y, Li Y, Zhou Z, Ma M, Fu K.
    Biomed Pharmacother; 2017 Nov 31; 95():922-928. PubMed ID: 28915533
    [Abstract] [Full Text] [Related]

  • 4. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA, Huang WC, Lee WH, Wu A, Wang LS, Hsiao M, Yeh CT, Chao TY.
    BMC Cancer; 2016 Feb 25; 16():160. PubMed ID: 26917489
    [Abstract] [Full Text] [Related]

  • 5. Long non-coding RNA linc00921 suppresses tumorigenesis and epithelial-to-mesenchymal transition of triple-negative breast cancer via targeting miR-9-5p/LZTS2 axis.
    Zhang J, Zhang L, Wang J, Zhao J, Zhao X, Zhang C, Han P, Geng C.
    Hum Cell; 2022 May 25; 35(3):909-923. PubMed ID: 35179718
    [Abstract] [Full Text] [Related]

  • 6. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway.
    Qiao Y, Wang B, Yan Y, Niu L.
    Environ Toxicol; 2022 Oct 25; 37(10):2398-2411. PubMed ID: 35730485
    [Abstract] [Full Text] [Related]

  • 7. LncRNA-HAGLR motivates triple negative breast cancer progression by regulation of WNT2 via sponging miR-335-3p.
    Jin L, Luo C, Wu X, Li M, Wu S, Feng Y.
    Aging (Albany NY); 2021 Aug 10; 13(15):19306-19316. PubMed ID: 34375306
    [Abstract] [Full Text] [Related]

  • 8. lncRNA LUCAT1/ELAVL1/LIN28B/SOX2 Positive Feedback Loop Promotes Cell Stemness in Triple-Negative Breast Cancer.
    Xia L, Wang H.
    Breast J; 2022 Aug 10; 2022():7689718. PubMed ID: 35711895
    [Abstract] [Full Text] [Related]

  • 9. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD.
    Wu D, Jia H, Zhang Z, Li S.
    Bioorg Chem; 2021 Apr 10; 109():104722. PubMed ID: 33618253
    [Abstract] [Full Text] [Related]

  • 10. HIF-1α/Malat1/miR-141 Axis Activates Autophagy to Increase Proliferation, Migration, and Invasion in Triple-negative Breast Cancer.
    Xu F, Hu Y, Gao J, Wang J, Xie Y, Sun F, Wang L, Miyamoto A, Xia O, Zhang C.
    Curr Cancer Drug Targets; 2023 Apr 10; 23(5):363-378. PubMed ID: 36579395
    [Abstract] [Full Text] [Related]

  • 11. Long non-coding RNA ANRIL promotes carcinogenesis via sponging miR-199a in triple-negative breast cancer.
    Xu ST, Xu JH, Zheng ZR, Zhao QQ, Zeng XS, Cheng SX, Liang YH, Hu QF.
    Biomed Pharmacother; 2017 Dec 10; 96():14-21. PubMed ID: 28961506
    [Abstract] [Full Text] [Related]

  • 12. lncRNA GHET1 Promotes the Progression of Triple-Negative Breast Cancer via Regulation of miR-377-3p/GRSF1 Signaling Axis.
    Wang Y, Li C.
    Comput Math Methods Med; 2022 Dec 10; 2022():8366569. PubMed ID: 35509860
    [Abstract] [Full Text] [Related]

  • 13. LncRNA LUCAT1 facilitates tumorigenesis and metastasis of triple-negative breast cancer through modulating miR-5702.
    Mou E, Wang H.
    Biosci Rep; 2019 Sep 30; 39(9):. PubMed ID: 31399501
    [Abstract] [Full Text] [Related]

  • 14. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
    Wang R, Huang Z, Qian C, Wang M, Zheng Y, Jiang R, Yu C.
    Biochem Biophys Res Commun; 2020 Jun 11; 526(4):1005-1012. PubMed ID: 32307083
    [Abstract] [Full Text] [Related]

  • 15. Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness.
    Shin VY, Chen J, Cheuk IW, Siu MT, Ho CW, Wang X, Jin H, Kwong A.
    Cell Death Dis; 2019 Mar 20; 10(4):270. PubMed ID: 30894512
    [Abstract] [Full Text] [Related]

  • 16. LncRNA LINC00173 enhances triple-negative breast cancer progression by suppressing miR-490-3p expression.
    Fan H, Yuan J, Li X, Ma Y, Wang X, Xu B, Li X.
    Biomed Pharmacother; 2020 May 20; 125():109987. PubMed ID: 32058222
    [Abstract] [Full Text] [Related]

  • 17. Long non-coding RNA SNHG8 enhances triple-negative breast cancer cell proliferation and migration by regulating the miR-335-5p/PYGO2 axis.
    Qian J, Lei X, Sun Y, Zheng L, Li J, Zhang S, Zhang L, Li W, Shi J, Jia W, Tang T.
    Biol Direct; 2021 Aug 06; 16(1):13. PubMed ID: 34362407
    [Abstract] [Full Text] [Related]

  • 18. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p.
    Wang L, Luan T, Zhou S, Lin J, Yang Y, Liu W, Tong X, Jiang W.
    Cancer Med; 2019 Aug 06; 8(9):4389-4403. PubMed ID: 31215169
    [Abstract] [Full Text] [Related]

  • 19. Long non-coding RNA CCAT2 promotes oncogenesis in triple-negative breast cancer by regulating stemness of cancer cells.
    Xu Z, Liu C, Zhao Q, Lü J, Ding X, Luo A, He J, Wang G, Li Y, Cai Z, Wang Z, Liu J, Liu S, Li W, Yu Z.
    Pharmacol Res; 2020 Feb 06; 152():104628. PubMed ID: 31904506
    [Abstract] [Full Text] [Related]

  • 20. Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development.
    Jin C, Yan B, Lu Q, Lin Y, Ma L.
    Tumour Biol; 2016 Jun 06; 37(6):7383-94. PubMed ID: 26676637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.